Recognition of rare hemoglobin variants by hemoglobin A1c measurement procedures

Sydney W. Strickland, Sean T. Campbell, Randie R. Little, David E. Bruns, Lindsay A.L. Bazydlo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Unrecognized hemoglobinopathies can lead to measured hemoglobin A1c (Hb A1c) concentrations that are erroneous or misleading. We determined the effects of rare hemoglobin variants on capillary electrophoresis (CE) and HPLC methods for measurement of Hb A1c. Methods We prospectively investigated samples in which Hb A1c was measured by CE during a 14-month period. For samples in which the electropherograms suggested the presence of rare hemoglobinopathies, hemoglobin variants were identified by molecular analysis or by comparison with electropherograms of known variants. When sample volume permitted, Hb A1c was measured by 2 HPLC measurement procedures and by boronate affinity HPLC. Results Hb A1c was measured by CE in 33,859 samples from 26,850 patients. 15 patients (0.06%) were identified as having rare hemoglobinopathies: Hbs A2 prime, Agenogi, Fannin-Lubbock I, G Philadelphia, G San Jose, J Baltimore, La Desirade, N Baltimore, Nouakchott, and Roanne. Among 6 of these samples tested by 2 ion-exchange HPLC methods, the rare Hb was detected by both HPLC methods in only one sample, and none were detected by boronate affinity HPLC. The mean of the Hb A1c results of 2 HPLC methods differed from the result of the CE method by 0.7–2.2% Hb A1c in samples with variant hemoglobins versus < 0.2% Hb A1c in samples without variants. Conclusion Measurement procedures differ in the ability to detect the presence of rare Hb variants and to quantify Hb A1c in patients who harbor such variants.

Original languageEnglish (US)
Pages (from-to)67-74
Number of pages8
JournalClinica Chimica Acta
Volume476
DOIs
StatePublished - Jan 2018
Externally publishedYes

Fingerprint

Hemoglobins
High Pressure Liquid Chromatography
Capillary electrophoresis
Capillary Electrophoresis
Hemoglobinopathies
Baltimore
Ion Exchange
Ports and harbors
varespladib methyl
Ion exchange

Keywords

  • Boronate affinity chromatography
  • Capillary electrophoresis
  • Diabetes
  • Hemoglobin A
  • Hemoglobin variants
  • Ion-exchange HPLC

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Recognition of rare hemoglobin variants by hemoglobin A1c measurement procedures. / Strickland, Sydney W.; Campbell, Sean T.; Little, Randie R.; Bruns, David E.; Bazydlo, Lindsay A.L.

In: Clinica Chimica Acta, Vol. 476, 01.2018, p. 67-74.

Research output: Contribution to journalArticle

Strickland, Sydney W. ; Campbell, Sean T. ; Little, Randie R. ; Bruns, David E. ; Bazydlo, Lindsay A.L. / Recognition of rare hemoglobin variants by hemoglobin A1c measurement procedures. In: Clinica Chimica Acta. 2018 ; Vol. 476. pp. 67-74.
@article{9477f310032e4514a080ea94bb65e68f,
title = "Recognition of rare hemoglobin variants by hemoglobin A1c measurement procedures",
abstract = "Background Unrecognized hemoglobinopathies can lead to measured hemoglobin A1c (Hb A1c) concentrations that are erroneous or misleading. We determined the effects of rare hemoglobin variants on capillary electrophoresis (CE) and HPLC methods for measurement of Hb A1c. Methods We prospectively investigated samples in which Hb A1c was measured by CE during a 14-month period. For samples in which the electropherograms suggested the presence of rare hemoglobinopathies, hemoglobin variants were identified by molecular analysis or by comparison with electropherograms of known variants. When sample volume permitted, Hb A1c was measured by 2 HPLC measurement procedures and by boronate affinity HPLC. Results Hb A1c was measured by CE in 33,859 samples from 26,850 patients. 15 patients (0.06{\%}) were identified as having rare hemoglobinopathies: Hbs A2 prime, Agenogi, Fannin-Lubbock I, G Philadelphia, G San Jose, J Baltimore, La Desirade, N Baltimore, Nouakchott, and Roanne. Among 6 of these samples tested by 2 ion-exchange HPLC methods, the rare Hb was detected by both HPLC methods in only one sample, and none were detected by boronate affinity HPLC. The mean of the Hb A1c results of 2 HPLC methods differed from the result of the CE method by 0.7–2.2{\%} Hb A1c in samples with variant hemoglobins versus < 0.2{\%} Hb A1c in samples without variants. Conclusion Measurement procedures differ in the ability to detect the presence of rare Hb variants and to quantify Hb A1c in patients who harbor such variants.",
keywords = "Boronate affinity chromatography, Capillary electrophoresis, Diabetes, Hemoglobin A, Hemoglobin variants, Ion-exchange HPLC",
author = "Strickland, {Sydney W.} and Campbell, {Sean T.} and Little, {Randie R.} and Bruns, {David E.} and Bazydlo, {Lindsay A.L.}",
year = "2018",
month = "1",
doi = "10.1016/j.cca.2017.11.012",
language = "English (US)",
volume = "476",
pages = "67--74",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - Recognition of rare hemoglobin variants by hemoglobin A1c measurement procedures

AU - Strickland, Sydney W.

AU - Campbell, Sean T.

AU - Little, Randie R.

AU - Bruns, David E.

AU - Bazydlo, Lindsay A.L.

PY - 2018/1

Y1 - 2018/1

N2 - Background Unrecognized hemoglobinopathies can lead to measured hemoglobin A1c (Hb A1c) concentrations that are erroneous or misleading. We determined the effects of rare hemoglobin variants on capillary electrophoresis (CE) and HPLC methods for measurement of Hb A1c. Methods We prospectively investigated samples in which Hb A1c was measured by CE during a 14-month period. For samples in which the electropherograms suggested the presence of rare hemoglobinopathies, hemoglobin variants were identified by molecular analysis or by comparison with electropherograms of known variants. When sample volume permitted, Hb A1c was measured by 2 HPLC measurement procedures and by boronate affinity HPLC. Results Hb A1c was measured by CE in 33,859 samples from 26,850 patients. 15 patients (0.06%) were identified as having rare hemoglobinopathies: Hbs A2 prime, Agenogi, Fannin-Lubbock I, G Philadelphia, G San Jose, J Baltimore, La Desirade, N Baltimore, Nouakchott, and Roanne. Among 6 of these samples tested by 2 ion-exchange HPLC methods, the rare Hb was detected by both HPLC methods in only one sample, and none were detected by boronate affinity HPLC. The mean of the Hb A1c results of 2 HPLC methods differed from the result of the CE method by 0.7–2.2% Hb A1c in samples with variant hemoglobins versus < 0.2% Hb A1c in samples without variants. Conclusion Measurement procedures differ in the ability to detect the presence of rare Hb variants and to quantify Hb A1c in patients who harbor such variants.

AB - Background Unrecognized hemoglobinopathies can lead to measured hemoglobin A1c (Hb A1c) concentrations that are erroneous or misleading. We determined the effects of rare hemoglobin variants on capillary electrophoresis (CE) and HPLC methods for measurement of Hb A1c. Methods We prospectively investigated samples in which Hb A1c was measured by CE during a 14-month period. For samples in which the electropherograms suggested the presence of rare hemoglobinopathies, hemoglobin variants were identified by molecular analysis or by comparison with electropherograms of known variants. When sample volume permitted, Hb A1c was measured by 2 HPLC measurement procedures and by boronate affinity HPLC. Results Hb A1c was measured by CE in 33,859 samples from 26,850 patients. 15 patients (0.06%) were identified as having rare hemoglobinopathies: Hbs A2 prime, Agenogi, Fannin-Lubbock I, G Philadelphia, G San Jose, J Baltimore, La Desirade, N Baltimore, Nouakchott, and Roanne. Among 6 of these samples tested by 2 ion-exchange HPLC methods, the rare Hb was detected by both HPLC methods in only one sample, and none were detected by boronate affinity HPLC. The mean of the Hb A1c results of 2 HPLC methods differed from the result of the CE method by 0.7–2.2% Hb A1c in samples with variant hemoglobins versus < 0.2% Hb A1c in samples without variants. Conclusion Measurement procedures differ in the ability to detect the presence of rare Hb variants and to quantify Hb A1c in patients who harbor such variants.

KW - Boronate affinity chromatography

KW - Capillary electrophoresis

KW - Diabetes

KW - Hemoglobin A

KW - Hemoglobin variants

KW - Ion-exchange HPLC

UR - http://www.scopus.com/inward/record.url?scp=85034575850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034575850&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2017.11.012

DO - 10.1016/j.cca.2017.11.012

M3 - Article

C2 - 29154790

AN - SCOPUS:85034575850

VL - 476

SP - 67

EP - 74

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -